INSIGHTS ON DRUG DEVELOPMENT
-
![Scaling Up Your E. Coli pDNA Process From Parameter Screening To Pilot Scale]( "Scaling Up Your E. Coli pDNA Process From Parameter Screening To Pilot Scale")
Scaling Up Your E. Coli pDNA Process From Parameter Screening To Pilot ScaleDiscover a systematic approach to scalable plasmid DNA production using E. coli OneShot Top10, which features DOE-driven optimization and key insights for efficient biomanufacturing success.
-
![SpectraMax iD5e multi-mode microplate reader plate tray open microplate showcased improve cell viability]( "Improved Cell Viability For Multi-Day Cell-Based Assays")
Improved Cell Viability For Multi-Day Cell-Based AssaysEnsure consistent cell health and assay reliability with controlled temperature and gas conditions. Discover how microplate readers with gas mixers enhance cell viability in live cell-based assays.
-
![GettyImages-1173354781 protein degradation]( "Accelerating Small Molecule Protein Degrader Development Using High-Content Imaging")
Accelerating Small Molecule Protein Degrader Development Using High-Content ImagingHigh‑content imaging enables rapid discovery and optimization of small‑molecule protein degraders by delivering multiparametric, single‑cell insights that accelerate hit identification, SAR development, and lead advancement.
-
![GettyImages-158649166 assay]( "Getting The Most Out Of Cell-Based Assays With The Optimal Read Function")
Getting The Most Out Of Cell-Based Assays With The Optimal Read FunctionGain insight into a whole-well fluorescence analysis that improves sensitivity and reproducibility in cell-based assays by accounting for uneven cell distribution.
-
Why Reshoring Is An Essential Strategy For ADC Supply Chain Security2/24/2026
Biotechs reshoring their supply chains to Western regions to mitigate risk and improve reliability require experienced partners to effectively manage these complex transitions.
-
Where Speed Meets Complexity In Bioprocess Development6/18/2026
Bioprocessing faces mounting pressure to compress timelines, especially for mAbs, while complex modalities like bispecifics and gene therapies introduce technical challenges. Process intensification, scale-up translation, and comparability risks remain critical hurdles.
-
Advancing Drug Development With Optimized LC-MS/MS Bioanalysis5/7/2025
Explore the critical role of sample preparation optimization and the application of liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) in bioanalytical method development.
-
Drug Substance For Early Clinical Phase Initiation5/6/2026
Explore how proactive nitrosamine impurity risk assessment protects early clinical drug supply, minimizes development delays, and enables confident progression to first‑in‑human studies.
-
Injection Site Reaction Screening Methodology6/6/2025
Optimize drug formulations for solubility at physiological pH to reduce injection site reactions, enable high-concentration dosing, and enhance patient comfort and compliance.
DRUG DEVELOPMENT SOLUTIONS
-
![Decision Making GettyImages-872555022]( "Which Organ-Chip Design Is Right For You?")
Explore detailed product specifications and utilize a helpful decision tree to determine which organ-chip best meets the needs of your research.
-
![leica-microsystems-thunder-imager-em-cryo-clem-hero]( "Successful Experimental Investigations With Cryo Light Microscope")
THUNDER Imager EM Cryo CLEM
In-depth understanding of cellular structural biology
The THUNDER Imager EM Cryo CLEM is a cryo light microscope featuring opto-digital THUNDER technology. It provides the imaging data and secure cryo conditions you need for successful experimental investigations concerning structural biology. Precisely identify cellular structures of interest thanks to high resolution, haze-free imaging with THUNDER technology, then transfer the specimen seamlessly to your EM.
-
![GettyImages-1220710526 lab, research]( "Predict And Assign Fragment Ions")
Model MS fragmentation pathways and align predictions with experimental data to assign fragment ions faster. Streamline spectral interpretation and confirm compound identities with greater confidence.
-
![drug-delivery-GettyImages-2214027401]( "Drug Delivery Materials")
Learn how tailored lipids, polymers, and carbohydrate‑based materials strengthen targeted delivery, enhance stability, and support scalable development for emerging therapeutic modalities.
-
![ExionLC™ 2.0 and ExionLC™]( "ExionLC™ 2.0 and ExionLC™ 2.0+ Systems")
Reproducibility, reliability and carryover performance that meets your workflow demands, injection to injection, batch after batch.
ExionLC 2.0 and ExionLC 2.0+ systems provide full integration, control and compatibility with SCIEX mass spectrometers bringing together the speed and precision you expect for a complete solution that meets every challenge your lab faces.
